Entera Bio (ENTX) Financial Statements

446 Followers

Entera Bio Financial Overview

Entera Bio's market cap is currently $53.62M. The company's EPS TTM is $-0.06; its P/E ratio is -7.43; Entera Bio is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Mar 23	Dec 21
Income Statement
Total Revenue	$ 42.00K	$ 181.00K	$ 0.00	$ 134.00K	$ 571.00K
Gross Profit	$ -30.00K	$ 9.00K	$ -56.00K	$ -31.00K	$ 198.00K
Operating Income	$ -11.53M	$ -9.59M	$ -8.94M	$ -13.07M	$ -12.22M
EBITDA	$ -11.50M	$ -9.54M	$ -8.80M	$ -12.87M	$ -12.16M
Net Income	$ -11.44M	$ -9.54M	$ -8.89M	$ -13.07M	$ -12.19M
Balance Sheet
Cash & Short-Term Investments	$ 7.11M	$ 8.66M	$ 11.02M	$ 12.31M	$ 24.89M
Total Assets	$ 15.99M	$ 9.39M	$ 11.77M	$ 13.13M	$ 25.99M
Total Debt	$ 490.00K	$ 272.00K	$ 390.00K	$ 91.00K	$ 302.00K
Net Debt	$ -6.62M	$ -8.39M	$ -10.63M	$ -12.22M	$ -24.59M
Total Liabilities	$ 2.89M	$ 1.31M	$ 1.38M	$ 1.37M	$ 3.42M
Stockholders' Equity	$ 13.10M	$ 8.08M	$ 10.39M	$ 11.75M	$ 22.57M
Cash Flow
Free Cash Flow	$ -7.48M	$ -6.82M	$ -7.33M	$ -12.55M	$ -9.08M
Operating Cash Flow	$ -7.37M	$ -6.82M	$ -7.31M	$ -12.50M	$ -9.06M
Investing Cash Flow	$ -107.00K	$ -3.00K	$ -17.00K	$ -102.00K	$ -17.00K
Financing Cash Flow	$ 13.71M	$ 4.48M	$ 6.04M	$ 13.00K	$ 25.38M

Currency in USD

Entera Bio Earnings and Revenue History

Income Statement >

Entera Bio Debt to Assets

Balance Sheet >

Entera Bio Cash Flow

Cash Flow >

Entera Bio Forecast EPS vs Actual EPS

Earnings >